3 min read Health Phase 3 Trial Confirms Anifrolumab’s Efficacy for Lupus Patients Editorial 10 January, 2026 A recent phase 3 clinical trial has confirmed that subcutaneous anifrolumab, marketed as Saphnelo,...Read More
